Hwang Kun
Department of Plastic Surgery, Inha University School of Medicine, Incheon, Korea.
J Craniofac Surg. 2016 Nov;27(8):2154-2155. doi: 10.1097/SCS.0000000000003089.
The most serious complication of filler or fat injection is blindness. According to a recent systematic review of 98 patients of blindness provoked by filler or fat injection, only 2 patients had the outcome of a complete recovery of vision.In the literature, only 2 papers were found in which hyperbaric oxygen therapy (HBOT) was used in ophthalmic artery obstruction. However, no improvement of vision was obtained in either patient. Recently, the authors treated a patient who had central retinal vein occlusion and cilioretinal artery occlusion with HBOT (daily 2-hour sessions at 253 kPa for 14 days), and his visual acuity returned to normal.In central retinal artery obstruction, if the cilioretinal artery is present, it will maintain the thickness of the retina to a variable extent. Though the size of the cilioretinal artery and the area it supplies varies, 36.2% (32.1-40.2%) of people have a cilioretinal artery.Thereafter, HBOT might be applied to patients with central retinal artery occlusion following filler injection.
填充剂或脂肪注射最严重的并发症是失明。根据最近一项对98例因填充剂或脂肪注射引发失明患者的系统评价，仅有2例患者视力完全恢复。在文献中，仅发现2篇关于在眼动脉阻塞中使用高压氧疗法（HBOT）的论文。然而，这2例患者的视力均未得到改善。最近，作者用HBOT（在253 kPa下每日治疗2小时，共14天）治疗了1例患有视网膜中央静脉阻塞和睫状视网膜动脉阻塞的患者，其视力恢复正常。在视网膜中央动脉阻塞中，如果存在睫状视网膜动脉，它会在不同程度上维持视网膜厚度。尽管睫状视网膜动脉的大小及其供血面积各不相同，但36.2%（32.1 - 40.2%）的人有睫状视网膜动脉。此后，HBOT可能适用于填充剂注射后发生视网膜中央动脉阻塞的患者。
